Partner Eric McClafferty
and senior associate Brooke Ringel
co-authored the Pharmaceutical Executive
article “Minimizing Liability with Export Control Compliance.” The article discusses the significant legal and monetary risks that biopharmaceutical companies face for non-compliance with U.S. export control laws. The article goes on to discuss cost effective ways that organizations can build an export compliance component into an existing regulatory or biosecurity program.